Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cladribine Tablets in Relapsing Multiple Sclerosis (CLOCK-MS)
NCT03963375Phase 4Completed
- Start
- Oct 2019
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cladribine in multiple sclerosis (MS). Started Oct 2019; status: completed.
02
Drugs
cladribine
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT03963375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03963375.